Shoklo Malaria Research Unit: Clinical Trials

2 trials sponsored by Shoklo Malaria Research Unit, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Shoklo Malaria Research Unit: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
Tenofovir Disoproxil Fumarate - Hepatitis B
Phase 1 / Phase 2CompletedJohns Hopkins Bloomberg School of Public Health982018-05-242023-02-06
Phase2a Primaquine Dose Escalation Study
dihydroartemisinin-piperaquine, 0.125 mg/kg Primaquine, 0.5 mg/kg Primaquine - Malaria
Phase 2CompletedUniversity of California, San Francisco812013-09-012015-01-19

Conditions studied

Hepatitis B (1)  ·  Malaria (1)

Interventions

Primaquine (1)  ·  Tenofovir (1)

Countries

Mali (1)  ·  Thailand (1)

Top investigators

Alassane Dicko, MD (1)  ·  Roland Gosling, MD, PhD (1)  ·  Stephan Ehrhardt, MD (1)

Results publications

PMID 26906747, PMID 32912268, PMID 32928858